
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $2.7B | -- | -- | $2.88 | -- |
07/31/2025 | Q2 | $2.7B | -- | -- | $2.94 | -- |
04/30/2025 | Q1 | $2.4B | $2.3B | $1.72 | $2.04 | -$0.32 |
01/30/2025 | Q4 | $2.4B | $2.6B | $2.33 | $2.18 | $0.15 |
10/30/2024 | Q3 | $2.7B | $2.7B | $2.75 | $2.91 | -$0.16 |
07/31/2024 | Q2 | $2.8B | $2.8B | $2.56 | $3.01 | -$0.45 |
04/25/2024 | Q1 | $2.5B | $2.5B | $2.71 | $2.25 | $0.46 |
01/30/2024 | Q4 | $2.5B | $2.5B | $2.28 | $2.24 | $0.04 |
10/26/2023 | Q3 | -- | -- | $2.79 | $2.22 | $0.57 |
08/01/2023 | Q2 | -- | -- | $2.67 | $1.62 | $1.05 |
04/28/2023 | Q1 | -- | -- | $1.34 | $1.03 | $0.31 |
01/31/2023 | Q4 | -- | -- | $1.14 | $1.73 | -$0.59 |
10/27/2022 | Q3 | -- | -- | $0.90 | $1.18 | -$0.28 |
07/28/2022 | Q2 | -- | -- | $0.41 | $0.85 | -$0.44 |
04/27/2022 | Q1 | -- | -- | -$0.03 | $0.17 | -$0.20 |
01/26/2022 | Q4 | -- | -- | $0.09 | $0.43 | -$0.34 |
10/28/2021 | Q3 | -- | -- | $1.30 | -- | -- |
07/29/2021 | Q2 | -- | -- | $3.07 | $2.26 | $0.81 |
04/28/2021 | Q1 | -- | -- | $1.44 | $1.15 | $0.29 |
01/27/2021 | Q4 | -- | -- | $1.01 | $0.73 | $0.28 |
10/29/2020 | Q3 | -- | -- | $1.46 | $1.09 | $0.37 |
07/30/2020 | Q2 | -- | -- | $1.17 | $0.51 | $0.66 |
04/29/2020 | Q1 | -- | -- | $0.99 | $1.25 | -$0.26 |
01/29/2020 | Q4 | -- | -- | $1.10 | $1.16 | -$0.06 |
10/30/2019 | Q3 | -- | -- | $2.17 | $1.88 | $0.29 |
08/01/2019 | Q2 | -- | -- | $2.72 | $2.37 | $0.35 |
04/30/2019 | Q1 | -- | -- | $1.82 | $1.66 | $0.16 |
01/30/2019 | Q4 | -- | -- | $1.51 | -- | -- |
11/01/2018 | Q3 | -- | -- | $2.05 | -- | -- |
07/31/2018 | Q2 | -- | -- | $2.05 | -- | -- |
04/26/2018 | Q1 | -- | -- | $1.47 | -- | -- |
01/25/2018 | Q4 | -- | -- | $0.74 | -- | -- |
10/31/2017 | Q3 | -- | -- | $1.23 | -- | -- |
08/02/2017 | Q2 | -- | -- | $1.69 | -- | -- |
04/26/2017 | Q1 | -- | -- | $0.58 | -- | -- |
01/26/2017 | Q4 | -- | -- | $0.26 | -- | -- |
11/01/2016 | Q3 | -- | -- | $0.82 | -- | -- |
07/28/2016 | Q2 | -- | -- | $1.13 | -- | -- |
04/28/2016 | Q1 | -- | -- | $0.76 | -- | -- |
01/28/2016 | Q4 | -- | -- | $0.19 | -- | -- |
10/29/2015 | Q3 | -- | -- | $0.64 | -- | -- |
Oshkosh reported $2.3B worth of top line sales in its most recent quarter.
Oshkosh announced earnings per share of $1.72 which represents a miss of analyst forecast a $2.04 per share.
Oshkosh reported $399.9M that represents $6.15 per share over the last quarter.
Oshkosh's earnings are forecast to decrease from $10.35 per share to $11.33 per share next year representing a decrease of -0.3%.
Oshkosh's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.